Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

7 Jun 2018 07:00

RNS Number : 5676Q
Sopheon PLC
07 June 2018
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

At today's Annual General Meeting of Sopheon, the international provider of software and services that help organizations generate more revenues and profits from new products, the Board will give shareholders an update and review of the business.

 

In conjunction with a truly exceptional financial performance in 2017, we continue to advance our strategy to be the world's leading provider of enterprise-class innovation management solutions. Our vision has consistently led the market, and this is a market that continues to evolve and demonstrate considerable growth. We delivered a very strong finish to last year, resulting in all the Group's headline financial measures exceeding market expectations by a significant margin. Revenues rose to $28.5m from $23.2m in 2016. On the back of an already strong increase in profitability in 2016, EBITDA last year reached $8.0m, up from $5.6m the year before, and profit before tax was $5.1m, compared to $3.0m the year before. Alongside a realignment of our debt position, this resulted in net assets rising to $18.6m from $10.4m the year before, and net cash rising to $9.5m from $4.2m.

 

Both volume and average value of license transactions increased compared to the year before. Towards the end of 2017 we signed substantial deals with two industry leading, blue chip, companies in the USA and in Germany and we are now in the process of implementing our Accolade® solution globally in both cases. Such customers further validate the momentum and acceptance of Accolade as an enterprise platform within the largest and most influential corporations in the world. We saw more acceptance of our SaaS (Software as a Service) offering, with three new SaaS customers signed last year, and our recurring revenue base improved to over $12m by the end of the year compared to just under $10m the year before.

 

Sopheon's market differentiation continues to be validated. Sopheon is the only vendor recognized in three different Gartner Market Guides - for Strategy Execution Management Software; Innovation Management Tools; and Strategy & Innovation Roadmapping Tools - as well as in its Magic Quadrant for Project Portfolio Management Worldwide. In our view, the capabilities called for in all of these respective reports are required to deliver on the promise of connecting strategic planning and operational execution. In addition, Sopheon was named a Leader in the 2017 Forrester Wave™: Strategic Portfolio Management Tools. Further recent market validation was recognition by Consumer Goods Technology magazine, naming Sopheon as "Best in Category" in new product development and introduction as voted by readers. Collectively, these are major strategic milestones in establishing the credentials of both the Company and our market.

 

In order to deliver on our growth strategies as described in our annual report, we are executing on ambitious investment plans across multiple functional areas to scale for growth for 2018 and beyond. Where appropriate, we are also open to consideration of targeted M&A opportunities if consistent with our goals and focused investment criteria. Alongside strategic initiatives, we remain highly driven by revenue and profit objectives, and to stand behind this ambition we have proposed a maiden dividend, to be put to the Company's shareholders at today's meeting. Remaining on the corporate theme, we were delighted with the success of our oversubscribed secondary placing completed in mid-May, which expanded our institutional shareholder base and we are grateful for the support and demand shown by certain blue chip institutional investors for the Company's shares.

 

Outlook

 

The positive momentum has continued this year, and we are signing additional new business which in turn is underpinning the performance for the year. Full year revenue visibility for 2018 from contracted business and recurring revenue streams is now up 34% at $23.5m, compared to $17.5m at this time last year - an all-time high for our mid-year AGM report. This includes the effect of several perpetual license deals and major services extensions, as well as a further major SaaS deal closed during the current quarter.

 

The Board continues to be confident and enthusiastic about the prospects of the Company, the outturn for the year and the opportunity to continue to deliver on our vision.

 

 

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Giles Rolls (corporate finance)

Alice Lane (corporate broking)

finnCap

+ 44 (0) 20 7220 0500

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMLLFERRVIRIIT
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.